Supplementary Figure 1 from The mTOR Kinase Inhibitors, CC214-1 and CC214-2, Preferentially Block the Growth of EGFRvIII-Activated Glioblastomas
Beatrice Gini,Ciro Zanca,Deliang Guo,Tomoo Matsutani,Kenta Masui,Shiro Ikegami,Huijun Yang,David Nathanson, Genaro R. Villa,David Shackelford,Shaojun Zhu,Kazuhiro Tanaka,Ivan Babic,David Akhavan, Kelly Lin, Alvaro Assuncao,Yuchao Gu,Bruno Bonetti,Deborah S. Mortensen,Shuichan Xu,Heather K. Raymon,Webster K. Cavenee,Frank B. Furnari,C. David James,Guido Kroemer,James R. Heath,Kristen Hege,Rajesh Chopra,Timothy F. Cloughesy,Paul S. Mischel crossref（2023）
摘要
PDF file - 3457K, Time course dependent CC214-1 treatment in a panel of isogenic GBM cell lines, U87EGFRvIII, U251 and LN229.
查看译文
AI 理解论文
溯源树
样例
